Related references
Note: Only part of the references are listed.Amoxapine Inhibits the Delayed Rectifier Outward K+ Current in Mouse Cortical Neurons via cAMP/Protein Kinase A Pathways
Yan-Lin He et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease
Christian Luescher et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Inhibition of G-Protein-Activated Inwardly Rectifying K+ Channels by the Selective Norepinephrine Reuptake Inhibitors Atomoxetine and Reboxetine
Toru Kobayashi et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Adverse events, toxicity and post-mortem data on duloxetine: Case reports and literature survey
Eric L. Vey et al.
JOURNAL OF FORENSIC AND LEGAL MEDICINE (2010)
In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine
Evelyn D. Lobo et al.
CLINICAL PHARMACOKINETICS (2008)
Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum
Carolina Aguado et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice
Hans G. Cruz et al.
JOURNAL OF NEUROSCIENCE (2008)
Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin
Daniel Scherer et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine
Toru Kobayashi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
Catherine Heurteaux et al.
NATURE NEUROSCIENCE (2006)
Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation
Norio Hashimoto et al.
PHARMACOLOGICAL RESEARCH (2006)
G protein-activated inwardly rectifying potassium channels as potential therapeutic targets
Toru Kobayashi et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Antidepressants and seizures: emphasis on newer agents and clinical implications
SA Montgomery
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Drug therapy - The medical management of depression
JJ Mann
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine:: A 19-F MRS study
ME Henry et al.
NEUROPSYCHOPHARMACOLOGY (2005)
SNRIs: The pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants
SM Stahl et al.
CNS SPECTRUMS (2005)
The dual transporter inhibitor duloxetine: A review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression
FP Bymaster et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Fatal blood and tissue concentrations of more than 200 drugs
F Musshoff et al.
FORENSIC SCIENCE INTERNATIONAL (2004)
Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose
GK Isbister et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2004)
Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs
T Kobayashi et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption
M Uhr et al.
BIOLOGICAL PSYCHIATRY (2003)
Reduced ethanol-induced conditioned taste aversion and conditioned place preference in GIRK2 null mutant mice
KG Hill et al.
PSYCHOPHARMACOLOGY (2003)
Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants
IM Whyte et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2003)
Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac)
T Kobayashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh
H Bettahi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Block of volume-regulated anion channels by selective serotonin reuptake inhibitors
C Maertens et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2002)
Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels
EV Kuzhikandathil et al.
MOLECULAR PHARMACOLOGY (2002)
The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome: A combined in vivo cerebral microdialysis and behavioural study
AM Gray
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2002)
Nicotinic acetylcholine receptors as targets for antidepressants
RD Shytle et al.
MOLECULAR PSYCHIATRY (2002)
Functional characterization of an endogenous Xenopus oocyte adenosine receptor
T Kobayashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors
FP Bymaster et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1
BH Choi et al.
NEUROPHARMACOLOGY (2001)
The antidepressant imipramine inhibits the M-type K+ current in rat sympathetic neurons
JL Cuellar-Quintero et al.
NEUROREPORT (2001)
Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines
GC Terstappen et al.
NEUROPHARMACOLOGY (2001)
Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy
NR Bolo et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Glycosylation of GIRK1 at Asn119 and ROMK1 at Asn117 has different consequences in potassium channel function
A Pabon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Block of rat brain recombinant SK channels by tricyclic antidepressants and related compounds
JC Dreixler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Sertraline treatment for alcohol dependence: Interactive effects of medication and alcoholic subtype
HM Pettinati et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2000)
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression
JM Kent
LANCET (2000)
Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K+ (GIRK) channels expressed in Xenopus oocytes
T Kobayashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: A fluorine MRS study
ME Henry et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells
F Deak et al.
NEUROPHARMACOLOGY (2000)
Share Paper
